Question explored with the scientific record
And why would a newborn bleed?
The short version: newborn bleeding is most often from vitamin K deficiency, and the evidence for the standard intervention is unusually solid.
A newborn’s blood is a fragile colloid. Their liver makes clotting factors at about half the adult level [3]. Without enough vitamin K, those factors cannot activate, and the blood loses its ability to clot. This is called vitamin K deficiency bleeding (VKDB). The classic form happens in the first week of life and affects about 1 in 100 to 1 in 10,000 newborns who did not get vitamin K [3]. The late form, which peaks around weeks 2 to 8, is rarer but more dangerous: about 4 to 7 per 100,000 births, and it often bleeds into the brain [1, 3].
The intervention is a single intramuscular shot of vitamin K at birth. The evidence for it is unusually strong for a newborn intervention. A systematic review found that the shot cut the risk of any bleeding by about 27% and the risk of moderate-to-severe bleeding by about 81% compared to placebo [4]. For circumcision bleeding, the reduction was about 82% [4]. Countries that switched from oral to intramuscular vitamin K saw late VKDB drop from about 7 per 100,000 to near zero [4]. The oral route works less reliably, especially in breastfed babies, and requires multiple doses [2].
| Group | Bleeding risk | Reduction vs no prophylaxis |
|---|---|---|
| No vitamin K (classic VKDB) | 0.01% to 1% | — |
| No vitamin K (late VKDB) | 4.4 to 7.2 per 100,000 | — |
| Intramuscular vitamin K | Near zero for late VKDB | ~99% reduction |
| Oral vitamin K (3 doses) | 0.4 to 1.3 per 100,000 | ~80-90% reduction |
The shot is not risk-free. It contains preservatives and can cause local bruising or, very rarely, infection. The 2003 Pediatrics review noted that the association with childhood cancer was studied and not confirmed, but the studies were observational, not randomized [1]. The burden of proof for the shot is lower than for most newborn interventions because the alternative — no vitamin K — carries a real and measurable risk of brain hemorrhage.
My call: the vitamin K shot is one of the few newborn interventions where the benefit clearly outweighs the harm for nearly every infant. Confidence: high.
Sources used 4
-
Controversies Concerning Vitamin K and the Newborn
This paper discusses the prevention of vitamin K deficiency bleeding (VKDB) in newborns, emphasizing the effectiveness of parenteral vitamin K administration and addressing concerns about its association with childhood cancer.
DOI: 10.1542/peds.112.1.191 -
Use of Oral Vitamin K for Prevention of Late Vitamin K Deficiency Bleeding in Neonates When Injectable Vitamin K is Not Available
This study evaluates the effectiveness of oral vitamin K regimens for preventing late vitamin K deficiency bleeding (VKDB) in neonates when injectable vitamin K is unavailable, highlighting the need for multiple doses, especially in exclusively breast-fed infants.
DOI: 10.1345/aph.1Q769 -
The bleeding newborn: A review of presentation, diagnosis, and management
A comprehensive narrative review of bleeding in newborns, detailing developmental hemostasis, congenital and acquired causes, diagnostic approaches, and management strategies including a practical algorithm for evaluation and treatment.
DOI: 10.1016/j.siny.2015.12.002 -
Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review
This systematic review evaluates the burden of late vitamin K deficiency bleeding (VKDB) and the effectiveness of vitamin K prophylaxis in preventing VKDB in neonates, revealing significant incidence rates and the benefits of intramuscular administration.
DOI: 10.1038/jp.2016.30